electroCore Engages FNK IR to Execute Expanded Investor Relations Program
2024年9月24日 - 9:00PM
electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic
medicine and wellness company, announced today that it has engaged
FNK IR, an institutionally focused investor relations consulting
firm, to develop and deploy an expanded outreach and communications
program.
Dan Goldberger, Chief Executive Officer of electroCore,
commented, “electroCore has demonstrated strong financial
performance, delivering seven consecutive quarters of record
revenue and driving of five-year CAGR of 69%. With consistently
high gross margins, improving operating leverage and confidence
that we are on a path towards generating positive cash flow early
next year, we felt it was the right time to enhance our investor
relations effort.”
Rob Fink, Managing Partner of FNK IR, commented, “electroCore is
growing rapidly and operating efficiently. With a proven management
team, consistent margins, strong sales channels and accelerating
adoption within a large and growing market, we believe
electroCore’s investment proposition is compelling. Our work will
focus on broadening awareness of electroCore to expand the
company’s audience of relevant investors as management advances
efforts that will unlock and drive sustainable shareholder
value.”
About electroCore, Inc.electroCore, Inc. is a
commercial stage bioelectronic medicine and wellness company
dedicated to improving health through its non-invasive vagus nerve
stimulation (“nVNS”) technology platform. Our focus is the
commercialization of medical devices for the management and
treatment of certain medical conditions and consumer product
offerings utilizing nVNS to promote general wellbeing and human
performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
About FNK IRFNK IR is a highly strategic,
investor-minded investor relations consulting firm that helps
smaller and emerging public companies navigate the capital markets,
enhancing awareness, creditability and ultimately valuation. FNK
IR’s exclusively senior team has decades of experience investing
in, partnering with, and working at public companies. To learn
more, please visit www.fnkir.com
Forward-Looking StatementsThis press release
may contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Such
forward-looking statements include, but are not limited to,
statements regarding the implications of the retention of Fink IR,
broadening of investor audience, electroCore's business prospects,
its sales and marketing and product development plans, future cash
flow projections, anticipated costs, its product portfolio or
potential markets for its technologies, the availability and impact
of payor coverage, the potential of nVNS generally in particular to
accelerate training, and other statements that are not historical
in nature, particularly those using terminology such as
"anticipates," "expects," "believes," "intends," other words of
similar meaning, derivations of such words and the use of future
dates. Actual results could differ from those projected in any
forward-looking statements due to numerous factors. Such factors
include, among others, the ability to obtain additional financing
necessary to continue electroCore's business, sales and marketing
and product development plans, the uncertainties inherent in the
development of new products or technologies, the ability to
successfully commercialize nVNS products, competition in the
industry in which electroCore operates and general market
conditions. The results of earlier preclinical studies and clinical
trials may not be predictive of results of future preclinical
studies, clinical trials, or commercial success. All
forward-looking statements are made as of the date of this press
release, and electroCore undertakes no obligation to update
forward-looking statements or to update the reasons why actual
results could differ from those projected in the forward-looking
statements, except as required by law. Investors should refer to
all information set forth in this document and should also refer to
the disclosure of risk factors set forth in the reports and other
documents electroCore files with the SEC, available at
www.sec.gov.
ContactECOR Investor Relations(973)
302-9253investors@electrocore.com
Rob FinkFNK IR ecor@fnkir.com(646) 809-4048
electroCore (NASDAQ:ECOR)
過去 株価チャート
から 9 2024 まで 10 2024
electroCore (NASDAQ:ECOR)
過去 株価チャート
から 10 2023 まで 10 2024